arrow
M

Mohammad R. Ostovaneh

Johns Hopkins Bloomberg School of Public Health
H指数:24
被引数:1,943

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluating Incident Atrial Fibrillation and Incident Heart Failure as Time-varying Covariates for Time-to-Event Analysis Among Adults 55 Years and Older in the Multi-Ethnic Study of Atherosclerosis (MESA)

评估atrial fibrillation和heart failure作为时变协变量在时间-事件分析中的应用:基于Atherosclerosis多民族研究(MESA)中55岁及以上成年人群的研究

2025-02-030
OAAI
Ultra-high-resolution CT vs. invasive angiography for detecting hemodynamically significant coronary artery disease: Rationale and methods of the CORE-PRECISION multicenter study
2024-09-010
PRE
Myocardial fibrosis by T1 mapping magnetic resonance imaging predicts incident cardiovascular events and all-cause mortality: the Multi-Ethnic Study of Atherosclerosis

T1成像的心肌纤维化磁共振成像预测心血管事件和全因死亡率: 动脉粥样硬化的多种族研究

2022-02-1117
OA
Prognostic value of noninvasive combined anatomic/functional assessment by cardiac CT in patients with suspected coronary artery disease - Comparison with invasive coronary angiography and nuclear myocardial perfusion imaging for the five-year-follow up of the CORE320 multicenter study
2021-11-0114
OAAI
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial

自体间充质基质细胞和c-kit阳性心脏细胞单独或联合用于缺血性心力衰竭患者的II期研究: CCTRN CONCERT-HF试验

2021-04-13103
OAAI
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients The CCTRN SENECA Trial

CCTRN SENECA试验在蒽环类药物诱导的心肌病心力衰竭患者中的同种异体间充质细胞治疗

2020-11-0133
OAAI
Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial
2020-08-0481
OAAI
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial

polypill对心血管疾病的一级和二级预防的有效性 (PolyIran): 一项实用的集群随机试验

LANCET
IF88.5
2019-08-01217
OAAI